Influence of a pig respiratory disease on the pharmacokinetic behaviour of amoxicillin after oral ad libitum administration in medicated feed

被引:12
作者
Godoy, C. [1 ]
Castells, G. [1 ]
Marti, G. [2 ]
Capece, B. P. S. [1 ,3 ]
Perez, F. [4 ]
Colom, H. [5 ]
Cristofol, C. [1 ]
机构
[1] UAB, Dept Pharmacol Therapeut & Toxicol, Servei Anal Farmacs, Barcelona, Spain
[2] Lab JAER SA, Barcelona 08620, Spain
[3] Univ Eduardo Mondlane, Fac Vet, Dept Para Clin, Maputo, Mozambique
[4] Seguridad & Bienestar Anim SL Can Pericas Marata, Barcelona, Spain
[5] Univ Barcelona, Unitat Biofarm & Farmacocinet, Servei Anal Farmacs, Barcelona, Spain
关键词
BETA-LACTAM ANTIBIOTICS; DOSE-DEPENDENT ABSORPTION; LIQUID-CHROMATOGRAPHY; ACTINOBACILLUS-PLEUROPNEUMONIAE; ANTIMICROBIAL AGENTS; TISSUE DISTRIBUTION; FATTENING PIGS; TRACT TISSUES; IN-VITRO; BIOAVAILABILITY;
D O I
10.1111/j.1365-2885.2010.01220.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetic properties of amoxicillin in healthy and respiratory-diseased pigs were studied, after ad libitum administration of medicated feed. In addition, amoxicillin dose linearity and drug penetration into respiratory tract tissues were evaluated in diseased animals. The respiratory disease involves porcine reproductive and respiratory syndrome virus and bacterial agents such as Pasteurella multocida, Bordetella bronchiseptica and Streptococcus suis. Typical clinical signs and gross lesions of respiratory disease were observed. The plasma pharmacokinetic analysis was performed by means of a noncompartmental approach. After single intravenous bolus administration of amoxicillin to healthy pigs, the steady-state volume of distribution was 0.61 L/kg, the total plasma clearance was 0.83 L/h/kg and the mean residence time was 0.81 h. After oral bolus administration, the mean absorption time was 1.6 h and the peak plasma concentration (3.09 mu g/mL) reached at 1.1 h postadministration. The oral bioavailability was 34%. For oral ad libitum administration, plasma concentration-time profiles were related to the feeding behaviour. Plasma concentrations at steady-state were established between 12 and 120 h. The pharmacokinetic parameters calculated (C-maxss, C-minss, C-avss and AUC(24ss)) showed significantly lower values in healthy pigs compared to diseased animals. This was in accordance with the significantly higher amoxicillin bioavailability (44.7% vs. 14.1%) and longer absorption period observed in diseased pigs. Amoxicillin dose linearity in diseased animals was established in a dose range of 4-18 mg/kg. On the other hand, tissue distribution ratio in diseased animals was 0.65 for bronchial mucosa, 0.48 for lung tissue and 0.38 for lymph nodes. Our results suggest that the pharmacokinetic properties and disposition of amoxicillin can be influenced by the disease state or by related factors such as changes in the gastrointestinal transit.
引用
收藏
页码:265 / 276
页数:12
相关论文
共 85 条
[1]  
Agerso H, 2000, AM J VET RES, V61, P992, DOI 10.2460/ajvr.2000.61.992
[2]   Penetration of amoxycillin into the respiratory tract tissues and secretions in pigs [J].
Agerso, H ;
Friis, C .
RESEARCH IN VETERINARY SCIENCE, 1998, 64 (03) :245-250
[3]   Penetration of amoxycillin to the respiratory tract tissues and secretions in Actinobacillus pleuropneumoniae infected pigs [J].
Agerso, H ;
Friis, C ;
Nielsen, JP .
RESEARCH IN VETERINARY SCIENCE, 1998, 64 (03) :251-257
[4]  
Agerso H, 1998, J VET PHARMACOL THER, V21, P41, DOI 10.1046/j.1365-2885.1998.00107.x
[5]   Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation [J].
AliAbadi, FS ;
Lees, P .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 14 (04) :307-313
[6]   Relative oral bioavailability of microgranulated amoxicillin in pigs [J].
Anfossi, P ;
Zaghini, A ;
Grassigli, G ;
Menotta, S ;
Fedrizzi, G .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2002, 25 (05) :329-334
[7]  
Ang CYW, 1996, J AOAC INT, V79, P389
[8]  
Benfield D.A., 1999, Diseases of Swine, V8A, P201
[9]   New concepts in the pulmonary disposition of antibiotics [J].
BergogneBerezin, E .
PULMONARY PHARMACOLOGY, 1995, 8 (2-3) :65-81
[10]  
Bes N., 1997, Journal of Veterinary Pharmacology and Therapeutics, V20, P47